Eutilex - Model EU103 -Fully Humanized Therapeutic Monoclonal Antibody
FromEutilex Co.,Ltd.
Fully humanized therapeutic monoclonal antibody. This could convert type II macrophage to Type I. Anti-tumor efficacy of the antibody can be achieved by modulating tumor microenvironment.
Most popular related searches
human monoclonal antibody
monoclonal antibody
in vivo efficacy
therapeutic antibody
tumor targeting
tumor microenvironment
T-cell
drug target
immunotherapy
immunoglobulin G1
Indication
Solid tumor
Target /Drug class
Anti-human VSIG4 mAb
Development Stage
Non-clinical
- Humanized monoclonal antibody of the engineered IgG1/kappa
- Immunotherapeutic, anti-human VSIG4 antibody
- Regulator of macrophage differentiation : regulator of type? macrophage conversion
- Blockade of inhibition of cytotoxic T cell
